Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
---|---|---|---|---|---|
11.001.041 | Drug Testing In Pain Management And Substance Use Disorder Treatment | Dec 09, 2024 | Dec 20, 2025 | Patients in pain management programs and substance use disorder treatment may misuse prescribed opioids... | Ver |
11.001.042 | Fecal Calprotectin Testing | Jan 15, 2025 | Jan 20, 2026 | Calprotectin is a calcium- and zinc-binding protein that is a potential marker of intestinal inflammation.... | Ver |
11.001.044 | Antigen Leukocyte Antibody Test | Nov 15, 2024 | Nov 20, 2025 | The antigen leukocyte antibody test (alcat) is intended to diagnose intolerance to foods and other... | Ver |
11.001.046 | Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes | Mar 20, 2025 | Mar 20, 2026 | Improved accuracy of the identification of pregnant people at risk of preeclampsia and spontaneous preterm... | Ver |
11.001.047 | Multicancer Early Detection Testing | Jul 19, 2024 | Jul 20, 2025 | Many cancers appear to have a better prognosis if diagnosed early in their natural history. this has led to... | Ver |
11.002.001 | Systems Pathology In Prostate Cancer | Dec 10, 2020 | Policy Archived | Systems pathology, an approach that combines cellular and biologic features to standard clinical parameters,... | Ver |
11.002.003 | Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions | Dec 26, 2024 | Dec 20, 2025 | Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... | Ver |
11.002.004 | Cervical Cancer Screening Technologies With Pap And Hpv | Apr 28, 2022 | Policy Archived | Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... | Ver |
11.003.001 | Laboratory Tests For Heart And Kidney Transplant Rejection | Nov 15, 2024 | Nov 20, 2025 | Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... | Ver |
11.003.002 | Genetic Testing For Predisposition To Inherited Hypertrophic Cardiomyopathy | Apr 15, 2024 | Apr 20, 2025 | Familial hypertrophic cardiomyopathy is an inherited condition caused by a disease associated variant in 1 or... | Ver |
11.003.003 | Multimarker Serum Testing Related To Ovarian Cancer | Jan 20, 2025 | Jan 20, 2026 | A variety of serum biomarkers have been studied for their association with ovarian cancer. of particular... | Ver |
11.003.004 | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, MMR/MSI, HER2, and TMB) | Aug 23, 2024 | Aug 20, 2025 | Summary the epidermal growth factor receptor (egfr) is overexpressed in colorectal cancer (crc).... | Ver |
11.003.006 | Pruebas Genéticas para el Tratamiento Helico Bacter Pylori | May 12, 2016 | Policy Archived | ... | Ver |
11.003.008 | Cytochrome P450 Genotype-Guided Treatment Strategy | Jul 17, 2024 | Jul 20, 2025 | The cytochrome p450 (cyp450) family is involved in the metabolism of many currently administered drugs, and... | Ver |
11.003.009 | Molecular Analysis For Targeted Therapy Of Non-Small-Cell Lung Cancer | Dec 05, 2024 | Dec 20, 2025 | Over half of patients with non-small-cell lung cancer (nsclc) present with advanced and therefore incurable... | Ver |
11.003.010 | Genetic Testing Of Cadasil Syndrome | May 16, 2024 | May 20, 2025 | Variants in the notch3 gene have been causally associated with cerebral autosomal dominant arteriopathy with... | Ver |
11.003.011 | Genetic Testing To Select Melanoma Or Glioma Patients For Targeted Therapy | Aug 15, 2024 | Jul 20, 2025 | The identification of specific, targetable oncogenic “driver mutations” in a subset of melanomas... | Ver |
11.003.012 | Genetic Testing For Inherited Thrombophilia | Jun 18, 2024 | Jun 20, 2025 | Inherited thrombophilias are a group of disorders that predispose individuals to thrombosis. genetic testing... | Ver |
11.003.013 | Genetic Testing For Rett Syndrome | Jul 17, 2024 | Policy Archived | Rett syndrome (rtt), a neurodevelopmental disorder, is usually caused by pathogenic variants in the... | Ver |
11.003.014 | Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna | Sep 12, 2024 | Sep 20, 2025 | Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... | Ver |